US equities
|
MU
$989.57
▼-3.83%
META
$742.00
▲+3.25%
NVDA
$226.53
▼-1.20%
SNDK
$1,493.49
▼-5.58%
SPCX
$163.51
▲+0.58%
AMD
$591.89
▼-2.67%
MSFT
$539.88
▲+0.90%
TSLA
$378.14
▼-1.19%
MU
$989.57
▼-3.83%
META
$742.00
▲+3.25%
NVDA
$226.53
▼-1.20%
SNDK
$1,493.49
▼-5.58%
SPCX
$163.51
▲+0.58%
AMD
$591.89
▼-2.67%
MSFT
$539.88
▲+0.90%
TSLA
$378.14
▼-1.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Lexaria Bioscience Corp. - Common Stock
(NQ:
LEXX
)
3.235
-0.085 (-2.56%)
Delayed Quote
Updated: 3:28 PM EDT, Oct 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lexaria Bioscience Corp. - Common Stock
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
32
33
Next >
Dow Jumps 550 Points; Convey Health Solutions Shares Spike Higher
↗
June 21, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 550 points on Tuesday.
Via
Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
↗
June 21, 2022
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,.
Via
Benzinga
Lexaria Signs Manufacturing and License Agreements with BevNology
June 21, 2022
KELOWNA, BC / ACCESSWIRE / June 21, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce the...
From
Lexaria Bioscience Corp.
Via
AccessWire
CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Ground-Breaking Studies Opening ‘Doors Previously Closed to Disruptive New Technology’
June 17, 2022
Via
Investor Brand Network
Topics
Intellectual Property
CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Ground-Breaking Studies Opening ‘Doors Previously Closed to Disruptive New Technology’
June 17, 2022
Via
CannabisNewsWire
Topics
Intellectual Property
Lexaria Bioscience Corp. (NASDAQ: LEXX) Initiates Communication with the FDA Concerning Potential Treatment for Hypertension; Out-Licenses Its DehydraTECH Technology to International Markets
June 15, 2022
Via
Investor Brand Network
Lexaria Bioscience Corp. (NASDAQ: LEXX) and the Budding Alternative Nicotine Market
June 13, 2022
Via
CannabisNewsWire
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Grants DehydraTECH(TM) License to Ireland-Based AnodGen Bioceuticals
June 08, 2022
Via
Investor Brand Network
Topics
Intellectual Property
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Grants DehydraTECH(TM) License to Ireland-Based AnodGen Bioceuticals
June 08, 2022
Via
CannabisNewsWire
Topics
Intellectual Property
Lexaria Grants License to AnodGen Bioceuticals
June 08, 2022
KELOWNA, BC / ACCESSWIRE / June 8, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce the...
From
Lexaria Bioscience Corp.
Via
AccessWire
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Takes First Regulatory Step with FDA for Development of DehydraTECH-CBD in Treating Hypertension
June 06, 2022
Via
Investor Brand Network
Topics
Intellectual Property
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Takes First Regulatory Step with FDA for Development of DehydraTECH-CBD in Treating Hypertension
June 06, 2022
Via
CannabisNewsWire
Topics
Intellectual Property
Lexaria Files Pre-IND Meeting Request Letter with U.S. FDA
June 06, 2022
KELOWNA, BC / ACCESSWIRE / June 6, 2022 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce it has...
From
Lexaria Bioscience Corp.
Via
AccessWire
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Awards Exclusive License to Japan’s Premier Wellness Science Co.
June 03, 2022
Via
CannabisNewsWire
Topics
Intellectual Property
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Awards Exclusive License to Japan’s Premier Wellness Science Co.
June 03, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Lexaria Bioscience Corp. (NASDAQ: LEXX) Mines Potential of Helping Medicines Do What they Do, But Better
June 03, 2022
Via
Investor Brand Network
Lexaria Grants Exclusive License to Premier Wellness Science Co., Ltd. for Strategic and Long-Term Partnership in the Japanese Market
June 03, 2022
KELOWNA, BC / ACCESSWIRE / June 2, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce a...
From
Lexaria Bioscience Corp.
Via
AccessWire
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) DehydraTECH Footprint Extends to Europe with License Granted to Valcon Medical
June 02, 2022
Via
CannabisNewsWire
Topics
Cannabis
Intellectual Property
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) DehydraTECH Footprint Extends to Europe with License Granted to Valcon Medical
June 02, 2022
Via
Investor Brand Network
Topics
Cannabis
Intellectual Property
Lexaria Grants License to Valcon Medical for the European Market
June 02, 2022
KELOWNA, BC / ACCESSWIRE / June 2, 2022 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce the...
From
Lexaria Bioscience Corp.
Via
AccessWire
Topics
Cannabis
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports on 2022 Annual Meeting Voting
June 01, 2022
Via
CannabisNewsWire
Topics
Intellectual Property
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports on 2022 Annual Meeting Voting
June 01, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Lexaria Announces 2022 Annual Meeting Results
June 01, 2022
KELOWNA, BC / ACCESSWIRE / June 1, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the results of the...
From
Lexaria Bioscience Corp.
Via
AccessWire
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging DehydraTECH(TM) as It Looks to Tap into Various Markets
May 27, 2022
Via
CannabisNewsWire
Topics
Intellectual Property
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging DehydraTECH(TM) as It Looks to Tap into Various Markets
May 27, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging Growing Commercial Opportunities
May 27, 2022
Via
Investor Brand Network
Topics
Intellectual Property
NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) Establishing Foothold in Huge Nicotine Delivery Space
May 26, 2022
Via
Investor Brand Network
Lexaria Bioscience Corp. (NASDAQ: LEXX) Making Waves in the Growing Antiviral Drug Space with its DehydraTECH Technology
May 25, 2022
Via
CannabisNewsWire
Lexaria Bioscience Corp. (NASDAQ: LEXX) Making Waves in the Growing Antiviral Drug Space with its DehydraTECH Technology
May 25, 2022
Via
Investor Brand Network
Nicotine Surges as Smoking Sags
May 24, 2022
Via
Investor Brand Network
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
32
33
Next >
